BPC-157 + TB-500 blend vs KLOW

Name: BPC-157 + TB-500 blend vs KLOW
Published: 2026-10-24

Updated Oct 24, 20268 sources

Key differences

1KLOW adds GHK-Cu and KPV.
2Guides pick Wolverine for a specific injury and KLOW for chronic, inflammatory or skin-plus-repair goals.
3KLOW adds GHK-Cu and KPV. Wolverine is seen as more targeted for acute injury.

Facts from each record, in the same words as their own pages.

BPC-157 + TB-500 blend and KLOW side by side
	BPC-157 + TB-500 blend	KLOW
Category	Healing & recovery	Skin & hair, Healing & recovery, Immune
Evidence	No human trials	No human trials
FDA status	Not FDA approvedRegulatory	Not FDA approvedRegulatory
WADA	Prohibited	Prohibited
Half-life	No value for the blend. BPC-157 clears in under 30 minutes in rats and dogs. The TB-500 fragment has no human value; full-length thymosin beta-4 by IV lasted longer at higher doses.Competitor guide	No value for the blend. BPC-157 clears in under 30 minutes in rats and dogs. KPV is unpublished, and GHK-Cu and TB-500 have no established human values.Clinical study
Routes	Subcutaneous injection	Subcutaneous injection
Forms	Vial (powder)	Vial (powder)
Reported doses	250 to 1,500 mcg (subcutaneous injection) 0.5 to 2 mg (subcutaneous injection)	2 to 8 mg (subcutaneous injection)
Most cited frequency	Once daily	Once daily (7.5, 15, 22.5 then 15 units at 3 mL)
Vial sizes	10 mg, 20 mgCompetitor guide	80 mgCompetitor guide
Mixed vial keeps	Fridge at 2 to 8 C, never frozen.Competitor guide	Fridge at 2 to 8 C, dark, never frozen.Competitor guide
Protocols on file	8	8

Doses shown are what sources report, labelled by origin. Not medical advice.

8 sources, each checked by date. Record updated Oct 24, 2026. Numbers are restated in our own words and labelled by where they came from.